FHI-B:CA:TSX-CI Health Care Giants Covered Call ETF (CAD)

ETF | Others |

Last Closing

CAD 12.05

Change

0.00 (0.00)%

Market Cap

CAD 0.05B

Volume

3.25K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-13 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

+0.09 (+0.26%)

CAD 6.91B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

CAD 6.63B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.17 (+0.57%)

CAD 6.19B
PHYS-U:CA Sprott Physical Gold Trust

+0.10 (+0.40%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.39 (+1.06%)

CAD 4.54B
ZMMK:CA BMO Money Market Fund ETF Seri..

N/A

CAD 4.20B
HXT-U:CA Global X S&P/TSX 60 Index ETF

+0.29 (+0.61%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

N/A

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.18 (+1.66%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.07 (-0.31%)

CAD 2.78B

ETFs Containing FHI-B:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.59% 29% F 29% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.59% 28% F 27% F
Trailing 12 Months  
Capital Gain -5.42% 10% F 19% F
Dividend Return 1.72% 45% F 31% F
Total Return -3.70% 10% F 18% F
Trailing 5 Years  
Capital Gain 5.79% 35% F 34% F
Dividend Return 32.29% 86% B+ 73% C
Total Return 38.08% 40% F 37% F
Average Annual (5 Year Horizon)  
Capital Gain 3.78% 54% F 48% F
Dividend Return 4.48% 53% F 43% F
Total Return 0.70% 68% D+ 29% F
Risk Return Profile  
Volatility (Standard Deviation) 4.95% 80% B- 91% A-
Risk Adjusted Return 90.57% 93% A 90% A-
Market Capitalization 0.05B 45% F 23% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.